GS1 Standard Would Speed The Sale Of Returned Drugs After November Deadline
New messaging standard from GS1 would enable industry to sell most returned drugs after November DSCSA deadline without running afoul of the FDA.
You may also be interested in...
As expected, the FDA will not take enforcement action against wholesalers that are unable to comply with DSCSA’s saleable return verification requirements by the 27 November deadline.
Pharmaceutical Manufacturers Testing Use of Verification Router Services To Process Saleable Returns Under DSCSA
2020 is when supply chain partners must agree on a vision for the track-and-trace anticounterfeiting system due in November 2023, experts tell the Pink Sheet.